RISK FACTORS OF GLUCOCORTICOID-INDUCED DIABETES MELLITUS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ZABIHI YEGANEH MOJDEH; SADEGHI SAEIDEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Galen Medical Journal Year:2013 | Volume:2 | Issue:2 Page(s): 39-43

Download Full-Text

View:

340

Download:

196

Cites:

Information Journal Paper

Title

RISK FACTORS OF GLUCOCORTICOID-INDUCED DIABETES MELLITUS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Author(s)

ZABIHI YEGANEH MOJDEH | SADEGHI SAEIDEH | Issue Writer Certificate

Keywords

DIABETES MELLITUS

GLUCOCORTICOID

SYSTEMIC LUPUS ERYTHEMATOSUS

RISK FACTOR

Abstract

Background: The aim of this study was to investigate the prevalence and associated factors of GLUCOCORTICOID-induced DIABETES MELLITUS (GIDM) in patients with SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) under GLUCOCORTICOID therapy. Martials and Methods: Patients with SLE who had received high-dose GLUCOCORTICOID therapy (prednisolone³1 mg/kg/day) at Rasoul Akram and Firoozgar hospitals were recruited during 2006-2011. Results: A total of 81 patients with SLE were evaluated.21 patients (25.9%) of them developed GIDM after high-dose GLUCOCORTICOID therapy. Univariate analysis of data showed that old age, family history of DIABETES MELLITUS (DM) and use of Mycophenolate mofetil were factors that would increase the likelihood of GIDM.Conclusion: In summary, GIDM was developed among 25.9% of patients with SLE after high-dose GLUCOCORTICOID therapy. Old age, family history of DM and use of Mycophenolate mofetil were determined to be factors responsible for increasing the risk of developing GIDM.

Cites

No record.

References

No record.

Cite

APA: Copy

ZABIHI YEGANEH, MOJDEH, & SADEGHI, SAEIDEH. (2013). RISK FACTORS OF GLUCOCORTICOID-INDUCED DIABETES MELLITUS IN SYSTEMIC LUPUS ERYTHEMATOSUS. GALEN MEDICAL JOURNAL, 2(2), 39-43. SID. https://sid.ir/paper/332543/en

Vancouver: Copy

ZABIHI YEGANEH MOJDEH, SADEGHI SAEIDEH. RISK FACTORS OF GLUCOCORTICOID-INDUCED DIABETES MELLITUS IN SYSTEMIC LUPUS ERYTHEMATOSUS. GALEN MEDICAL JOURNAL[Internet]. 2013;2(2):39-43. Available from: https://sid.ir/paper/332543/en

IEEE: Copy

MOJDEH ZABIHI YEGANEH, and SAEIDEH SADEGHI, “RISK FACTORS OF GLUCOCORTICOID-INDUCED DIABETES MELLITUS IN SYSTEMIC LUPUS ERYTHEMATOSUS,” GALEN MEDICAL JOURNAL, vol. 2, no. 2, pp. 39–43, 2013, [Online]. Available: https://sid.ir/paper/332543/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops